NuCana (NCNA) Cash from Investing Activities (2017 - 2025)

NuCana (NCNA) reported Cash from Investing Activities of $178242.3 for Q4 2025, up 531.24% on a YoY basis from $28237.0 in Q4 2024, and up 106.4% sequentially from $86359.2 in Q3 2025.

NuCana (NCNA) Cash from Investing Activities (2017 - 2025) Analysis & Trends

NuCana (NCNA) has 9 years of Cash from Investing Activities data on file, last reported at $178242.3 in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 531.24% year-over-year to $178242.3; the trailing twelve-month figure through Dec 2025 stood at $316225.9 (up 212.72% YoY), and the FY2025 full-year result was $209643.1, up 107.6% from the prior year.
  • Cash from Investing Activities rose to $178242.3 in Q4 2025, from $86359.2 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $3.4 million in Q3 2023 to a low of -$3.9 million in Q3 2021.
  • A 5-year average of -$42517.4 and a median of $28509.2 in 2024 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities sank 406.97% in 2021 and soared 3249.53% in 2023, its largest moves.
  • Tracing NCNA's Cash from Investing Activities over 5 years: stood at -$624128.9 in 2021, then surged by 130.07% to $187668.5 in 2022, then sank by 64.95% to $65781.0 in 2023, then slumped by 57.07% to $28237.0 in 2024, then surged by 531.24% to $178242.3 in 2025.
  • Business Quant data shows NCNA's Cash from Investing Activities at $178242.3 in Q4 2025, $86359.2 in Q3 2025, and $28237.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,380.63 Bn 66,380.34 Bn - -
2 Nanobiotix 1,910.39 Bn 1,910.33 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 470.95 Bn 466.16 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.92 Bn 61.16 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.06 Bn 62.06 Bn - -
8 Argenx Se 55.76 Bn 50.58 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn -25.54 Mn
10 NuCana 15.22 Bn 15.19 Bn - 178,242.27

Historic Data

Download Data
DateValue
Dec 31, 2025 178,242.27
Dec 31, 2025 178,242.27
Sep 30, 2025 86,359.18
Sep 30, 2025 86,359.18
Dec 31, 2024 28,237.04
Dec 31, 2024 28,237.04
Sep 30, 2024 23,387.40
Sep 30, 2024 23,387.40
Jun 30, 2024 -5,048.88
Jun 30, 2024 -5,048.88
Mar 31, 2024 54,546.28
Mar 31, 2024 54,546.28
Dec 31, 2023 65,781.05
Dec 31, 2023 65,781.05
Sep 30, 2023 3.36 Mn
Sep 30, 2023 3.36 Mn
Jun 30, 2023 28,781.35
Jun 30, 2023 28,781.35
Mar 31, 2023 198,128.05
Mar 31, 2023 198,128.05